Danny Talati, Pharm.D., MBA is Senior Vice President, Corporate Strategy at Cognesy Therapeutics. He has spent more than 20 years in the pharmaceutical industry in a variety of roles, including sales, medical and business development.
Prior to joining Cognesy, Dr. Talati was Head of Business Development at atai Life Sciences where he played a major role in building the company’s portfolio. He held roles at a number of companies, including ten years at Eli Lilly, primarily in the Neuroscience Medical division.
Dr. Talati earned a Doctor of Pharmacy degree from Northeastern University and an M.B.A. from London Business School.